Skip to main content
SpringerLink
Log in

Albumin-Bound Paclitaxel In Metastatic Breast Cancer

A Viewpoint by Nuhad Ibrahim

  • Adis Drug Profiles
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Winer EP, Berry DA, Woolf S, et al. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004 Jun 1; 22(11): 2061–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA

    Nuhad Ibrahim

Authors
  1. Nuhad Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibrahim, N. Albumin-Bound Paclitaxel In Metastatic Breast Cancer. Drugs 66, 949 (2006). https://doi.org/10.2165/00003495-200666070-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666070-00009

Keywords

Search

Navigation